Sirolimus reduces cancer risk after renal transplant

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1514, 2005-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus reduces cancer risk after renal transplant

Reactions Weekly, Vol. 1, Iss. 1079, 2005-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Ovarian and uterine cancer (first report for mycophenolate mofetil, sirolimus and tacrolimus) in renal transplant recipients: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Sirolimus reduces acute rejection in renal transplantation

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Sirolimus: Proteinuria in a renal transplant recipient: case report

Reactions Weekly, Vol. 1, Iss. 1099, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Sirolimus dominates tacrolimus post-renal transplant

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite